Milestone Pharmaceuticals's total assets for Q3 2025 were $87.75M, an increase of 85.06% from the previous quarter. MIST total liabilities were $67.25M for the fiscal quarter, a 3.20% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.